MEDIAN Technologies

165 articles about MEDIAN Technologies

• Median Technologies Reports Its Financial Results for H1 2018 and Announces Its Strategic Shift in Focus to Its Imaging Phenomics Platform iBiopsy®

  10/11/2018

  Median Technologies (Paris:ALMDT), the industry-leading Imaging Phenomics Company®, today reported its 2018 half-yearly results. Median Technologies’ Board of Directors approved the consolidated financial statements for the first half of 2018 on October 9, 2018.

• Median Technologies Receives the Forbes 2018 Futur40 Award and Special Recognition Prize for the “Health-Life Sciences” Company Category

  7/12/2018

  Median Technologies announces that on July 11, it received the 2018 Futur40 award and special recognition prize in the category “Health-Life Sciences”.

• Median Technologies to Attend the 2018 ASCO Annual Meeting, June 1-5, 2018, McCormick Place, Chicago, IL, USA

  5/31/2018

  Median Technologies announced that it will be exhibiting at the 2018 ASCO Annual Meeting.

• Median Technologies Launches ImageBank™

  4/26/2018

  Median Technologies announced today the launch of ImageBank™.

• Median Technologies Reports Full Year 2017 Financial Results

  4/12/2018

  Revenues increased 21% to €7.69 million for the full year 2017 Net new business of €14.69 million, increased backlog by 23% to €23 million for the full year Cash and cash equivalents are €28.29 million, as of December 31, 2017

• Median Technologies and CMIC HOLDINGS Co., Ltd. Announce Agreement to Provide Comprehensive Clinical Trial Services

  2/27/2018

  Median Technologies, the industry-leading Imaging Phenomics Company® (Paris:ALMDT) and CMIC HOLDINGS Co., Ltd. (CMIC), a leading Contract Research Organization (CRO) with services for development, manufacturing, sales, and marketing of pharmaceutical products, today announced a collaborative agreement for comprehensive clinical trial services.

• Median Technologies Announces Results of Deep Learning Study for Enhanced Prostate Segmentation - Helping to Advance Precision Medicine

  2/13/2018

  Study results will be presented at the SPIE Medical Imaging conference in Houston, TX, USA on February 14.

• Median Technologies Ranks in Deloitte Technology Fast 500 EMEA for 2017

  1/5/2018

  Median grew by 428% over the period with increasing demand of the company’s medical imaging contract research services or iCRO.

• Median Technologies Launches iSee- a Comprehensive Technology Platform to Enhance Medical Imaging Analysis in Clinical Trials

  12/14/2017

  iSee strengthens the iCRO offering by helping biopharmaceutical companies reduce project start-up time and improve user workflows.

• Median Technologies Inks a Research Collaboration Agreement for Lung Cancer Screening Programs With Xingtai People’s Hospital, Xingtai City, China

  12/7/2017

  Within the frame of the agreement, Median’s MediScan® image analysis technology will be used to conduct lung cancer screening programs organized under the aegis of Xingtai People’s Hospital in Xingtai City.

• Median Technologies Inks a Collaboration Agreement With Memorial Sloan Kettering Cancer Center for a Study Dealing with Prostate Cancer

  11/28/2017

  The collaboration between MSK and Median deals with the use of iBiopsy® for a retrospective study of MRI images of 200 patients who were diagnosed with prostate cancer and underwent radical prostatectomy, and for whom histological slides and analyses are available.

• Median Technologies Appoints Dr. Peter Bannister as Chief Technology Officer

  11/9/2017

  As Chief Technology Officer, Dr. Bannister is responsible for leading the development and scientific research teams at Median and ensuring that Median's products directly address the unmet healthcare needs identified by the company's clinical end users.

• Median Technologies to Present at Medidata NEXT Global 2017 to Discuss How New Technologies Can Optimize Image Management in Clinical Trials

  11/7/2017

  The Imaging Phenomics Company is pleased to announce that James Golando, Chief of Operations at Median Technologies will present on “Optimizing Imaging in Oncology Clinical Trials” during the upcoming Medidata NEXT Global 2017.

• Median Technologies Adds MediScan to Its Product Portfolio

  11/1/2017

  Median Technologies intends to leverage Mediscan for strengthening the commercial development and market penetration of its application portfolio in Asia and more specifically in China.

• Median Technologies Strengthens Its Medical Leadership With the Appointment of Dr. Loan Hoang-Sayag as Chief Medical Officer and the Appointment of Dr. Fabien Ricard as Medical Director, North America

  10/27/2017

  Median Technologies, The Imaging Phenomics Company announces the appointment of Dr. Loan Hoang-Sayag as Chief Medical Officer and the appointment of Dr. Fabien Ricard as Medical Director, North America.

• Median Technologies Appoints Vivian Wang As General Manager, China and Takashi Hayashi As Managing Director, Japan

  10/20/2017

  Median Technologies, The Imaging Phenomics Company today announces the appointment of Vivian Wang as General Manager, China and the appointment of Takashi Hayashi as Managing Director, Japan.

• Median Technologies To Attend The Liver Meeting® Of The American Association For The Study Of Liver Diseases To Be Held October 20-24, 2017 In Washington, DC, USA

  10/18/2017

  Median Technologies announced today that it will participate in The Liver Meeting, the annual meeting of the Association for the Study of Liver Diseases October 20-24.

• MEDIAN Technologies: H1 2017 Results: Half-Year Marked By Major Investments To Structure The Company And Prepare For The Future

  10/10/2017

• MEDIAN Technologies To Lead A Scientific And Medical Round Table To Discuss The Application Of Its Groundbreaking Imaging Phenomics Platform Ibiopsy For Nonalcoholic Steatohepatitis (NASH)

  9/6/2017

• MEDIAN Technologies And Medidata Solutions, Inc. Partner To Deliver Differentiated Image Management Services In Clinical Trials

  6/22/2017